Neutralizing antibodies to interferon β-1b are not associated with disease worsening in multiple sclerosis.

Authors: Farrell, Rachel¹; Bendtzen, Klaus²; Bertolotto, Antonio³; Clark, Berwyn⁴; Comabella, Manuel⁵; Deisenhammer, Florian⁶; Fogdell-Hahn, Anna⁷; Giovannoni, Gavin⁸; Hartung, Hans Peter⁹; Hemmer, Bernard¹⁰; Hillert, Jan¹¹; Kappos, Ludwig¹²; Killestein, Joep¹³; Lindberg, Raija¹⁴; Montalban, Xavier⁵; Polman, Chris¹³; Sorensen, Per Soelberg¹⁵; Goodin, D.S.¹⁶; Hurwitz, B.¹⁷; Noronha, A.¹⁸

Source: The Journal of International Medical Research, Volume 36, Number 1, January 2008 , pp. 204-210(7)

Publisher: Field House Publishing

Articles that cite this article?

Document Type: Letter section

Affiliations: 1: Institute of Neurology, Queen Square, London WC1N 3BG, UK; Institute of Cell and Molecular Science, Queen Mary University of London, London, UK 2: Institute for Inflammation Research IIR 7521, Rigshospitalet National University Hospital, Copenhagen, Denmark; and BioMonitor Ltd, Symbion Science Park, Copenhagen, Denmark 3: Centrop riferiferimento regionale Sclerosi Multipla (CRESM) and Neurobiology Clinic, San Luigi University Hospital, Turin, Italy 4: Lab 21 Ltd, Fareham, UK 5: Unit for Clinical Neuroimmunology, General University Hospital of Vall Hebron, Barcelona, Spain 6: Department of Neurology, University of Innsbruck, Innsbruck, Austria 7: Clinical Neuroscience, Division of Neurology, Karolinska Institute, Huddinge, Sweden 8: Barts and the London NHS Trust, Queen Mary University of London, London, UK 9: Department of Neurology, Heinrich-Heine-University, Duesseldorf, Germany 10: Klinik für Neurologie mit Poliklinik Klinikum rechts der Isar, Ismaninger, Munich, Germany 11: Karolinska Institute, Huddinge, Sweden 12: University Hospital, Basel, Switzerland 13: VU Medical Center, Amsterdam, The Netherlands 14: Clinical Neuroimmunology Laboratory, University Hospital, Basel, Switzerland 15: Danish Multiple Sclerosis Research Center, Department of Neurology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark 16: Department of Neurology, Room M794, University of California, San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143-0114, USA 17: Department of Neurology, Duke University Medical Center, Durham, NC, USA 18: Department of Neurology, University of Chicago, Chicago, IL, USA

Publication date: 2008-01-01

• The Journal of International Medical Research (JIMR) is a leading peer reviewed journal offering exceptional publication speed for medical, clinical and pre-clinical research. Reviews, case studies, preliminary communications, post-marketing surveillance, pharmacoeconomic and managed care studies are also welcome. Supplements publish symposium proceedings or collections of medical, pre-clinical or clinical data and enquiries from potential sponsors are welcome. JIMR is widely indexed and abstracted, including Medline, Current Contents and Excerpta Medica (EMBASE).
• Editorial Board
• Information for Authors
• Submit a Paper
• Subscribe to this Title
• Information for Advertisers
• Terms & Conditions
• ingentaconnect is not responsible for the content or availability of external websites

• In this: publication
• By this: publisher
• In this Subject: Internal Medicine ,  Pharmacology ,  Public Health
• By this author: Farrell, Rachel ;  Bendtzen, Klaus ;  Bertolotto, Antonio ;  Clark, Berwyn ;  Comabella, Manuel ;  Deisenhammer, Florian ;  Fogdell-Hahn, Anna ;  Giovannoni, Gavin ;  Hartung, Hans Peter ;  Hemmer, Bernard ;  Hillert, Jan ;  Kappos, Ludwig ;  Killestein, Joep ;  Lindberg, Raija ;  Montalban, Xavier ;  Polman, Chris ;  Sorensen, Per Soelberg ;  Goodin, D.S. ;  Hurwitz, B. ;  Noronha, A.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers